Polina A. Demina

Cooley advised Everbridge, a global leader in critical event management and national public warning solutions, on its definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valuing Everbridge at approximately $1.8 billion.

Cooley advised Allovue, a top provider of K-12 financial planning, budgeting and analytics software in the US, on its acquisition by PowerSchool, a leading provider of cloud-based software for K-12 education in North America.

Read more

Cooley advised Morphimmune, a private biotechnology company, in its definitive merger agreement with Immunome and $125 million private investment.

Cooley advised Sol de Janeiro, an innovative leader in the global prestige body care market, on its sale of a majority stake to The L’Occitane Group, an international group that manufactures and retails beauty and well-being products that are rich in natural and organic ingredients. Partner David Silverman led the team advising Sol de Janeiro.

Read more

Cooley advised Five Prime Therapeutics, a publicly traded clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, on its agreement to sell to Amgen in an all-cash transaction with an equity value of approximately $1.9 billion. Partners Jamie Leigh, Ian Nussbaum and Laura Berezin led the Cooley team advising Five Prime.